AU757021B2 - Non-identical genes and their application in improved molec ular adjuvants - Google Patents

Non-identical genes and their application in improved molec ular adjuvants Download PDF

Info

Publication number
AU757021B2
AU757021B2 AU17762/99A AU1776299A AU757021B2 AU 757021 B2 AU757021 B2 AU 757021B2 AU 17762/99 A AU17762/99 A AU 17762/99A AU 1776299 A AU1776299 A AU 1776299A AU 757021 B2 AU757021 B2 AU 757021B2
Authority
AU
Australia
Prior art keywords
polypeptide
nucleic acid
dna
sequence
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17762/99A
Other languages
English (en)
Other versions
AU1776299A (en
Inventor
Vivienne Frances Cox
Pamela Jane Elizabeth Rowling
Richard Anthony Godwin Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adprotech PLC
Original Assignee
Adprotech PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech PLC filed Critical Adprotech PLC
Publication of AU1776299A publication Critical patent/AU1776299A/en
Application granted granted Critical
Publication of AU757021B2 publication Critical patent/AU757021B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU17762/99A 1997-12-31 1998-12-30 Non-identical genes and their application in improved molec ular adjuvants Ceased AU757021B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9727512 1997-12-31
GBGB9727512.7A GB9727512D0 (en) 1997-12-31 1997-12-31 Fuzzy genes and their application in molecular adjuvants
PCT/GB1998/003918 WO1999035260A1 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molec ular adjuvants

Publications (2)

Publication Number Publication Date
AU1776299A AU1776299A (en) 1999-07-26
AU757021B2 true AU757021B2 (en) 2003-01-30

Family

ID=10824333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17762/99A Ceased AU757021B2 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molec ular adjuvants

Country Status (10)

Country Link
US (1) US6770631B1 (cg-RX-API-DMAC7.html)
EP (1) EP1042467B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002500042A (cg-RX-API-DMAC7.html)
AT (1) ATE403721T1 (cg-RX-API-DMAC7.html)
AU (1) AU757021B2 (cg-RX-API-DMAC7.html)
CA (1) CA2317020A1 (cg-RX-API-DMAC7.html)
DE (1) DE69839848D1 (cg-RX-API-DMAC7.html)
GB (1) GB9727512D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ505827A (cg-RX-API-DMAC7.html)
WO (1) WO1999035260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008582D0 (en) * 2000-04-08 2000-05-31 Adprotech Plc DNA immunization vectors
WO2001092295A2 (en) * 2000-05-30 2001-12-06 University Of Toronto Ligands for cd21 and compositions thereof for modulating immune responses
GB0025229D0 (en) * 2000-10-14 2000-11-29 Adprotech Ltd Veterinary immunisation vectors
WO2002059297A2 (en) 2001-01-25 2002-08-01 Evolva Biotech A/S A library of a collection of cells
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
GB0204154D0 (en) * 2002-02-22 2002-04-10 Adprotech Ltd Cat immunisation vectors
WO2004016283A2 (en) * 2002-08-14 2004-02-26 Avidis Sa Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
US7664748B2 (en) * 2004-07-12 2010-02-16 John Eric Harrity Systems and methods for changing symbol sequences in documents
JP5241012B2 (ja) * 2005-07-15 2013-07-17 ノバルティス アーゲー Ｐａｍｐｓ、病原体関連分子パターン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612340B2 (en) 1986-11-04 1991-07-11 Protein Polymers Technologies, Inc. Construction of synthetic dna and its use in large polypeptide synthesis
US6018030A (en) * 1986-11-04 2000-01-25 Protein Polymer Technologies, Inc. Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
US5641648A (en) * 1986-11-04 1997-06-24 Protein Polymer Technologies, Inc. Methods for preparing synthetic repetitive DNA
JPH0829098B2 (ja) * 1988-01-05 1996-03-27 寳酒造株式会社 細胞接着活性ポリペプチド
WO1993012257A1 (en) * 1991-12-12 1993-06-24 Hybritech Incorporated Enzymatic inverse polymerase chain reaction library mutagenesis
US5861285A (en) * 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
US5763733A (en) * 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
GB9424631D0 (en) 1994-12-06 1995-01-25 Lynxvale Ltd Modulating the immune response
DE19756975A1 (de) * 1997-12-20 1999-06-24 Hoechst Marion Roussel De Gmbh Bindungspartner für Inhibitoren von cyclinabhängigen Kinasen und ihre Verwendung zur Suche nach Inhibitoren, zur Diagnose oder zur Therapie einer Erkrankung

Also Published As

Publication number Publication date
US6770631B1 (en) 2004-08-03
CA2317020A1 (en) 1999-07-15
EP1042467A1 (en) 2000-10-11
NZ505827A (en) 2003-03-28
DE69839848D1 (de) 2008-09-18
AU1776299A (en) 1999-07-26
WO1999035260A1 (en) 1999-07-15
EP1042467B1 (en) 2008-08-06
GB9727512D0 (en) 1998-02-25
JP2002500042A (ja) 2002-01-08
ATE403721T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
KR100222163B1 (ko) 캡시드를 형성하고 시스테인 변형된 키메라 ms-2 코트 단백질
US6072039A (en) Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
Löwenadler et al. A gene fusion system for generating antibodies against short peptides
US5633234A (en) Lysosomal targeting of immunogens
AU652124B2 (en) Stabilized protein or peptide conjugates
ES2285706T3 (es) Tecnologia de expresion y exportacion de proteinas como inmunofusinas.
CN111499725A (zh) 结合IL-4受体α的泪脂质运载蛋白突变蛋白
EP1012280A1 (en) Trimerising module
CA2131389A1 (en) Thrombin receptor antagonists
US6770631B1 (en) Non-identical genes and their application in improved molecular adjuvants
JPH05502025A (ja) 第８：ｃ因子活性を有するタンパク質複合体およびその製法
Chang et al. Identification of a nuclear localization sequence in the polyomavirus capsid protein VP2
Rindisbacher et al. Production of Human Secretory Component with Dimeric IgA Binding Capacity Using Viral Expression Systems∗
KR940005586B1 (ko) 플라비 비루스 항원
Airenne et al. Recombinant avidin and avidin–fusion proteins
ES2357622T3 (es) Péptido etiqueta que contiene cisteína para la conjugación específica de sitio de proteínas.
US5763284A (en) Methods for peptide synthesis and purification
US5543264A (en) Co-factor activated recombinant adenovirus proteinases
JP5000481B2 (ja) 抗原と結合したクラスｉｉｍｈｃリガンドを含む結合産物、その使用方法およびそれを備える免疫原性組成物
WO2010066090A1 (zh) 凋亡素-ec-sod羧基末端蛋白转导域融合蛋白
ES2310988T3 (es) Particulas para terapia genica.
JP2974348B2 (ja) ヘモフイルス インフルエンザｂ型の膜タンパク及びペプチド
CN119161495A (zh) 呼吸道合胞病毒重构多肽及其应用
CA2247615A1 (en) Down-regulation resistant c3 convertase
CZ74797A3 (en) Composition for specific intracellular introduction of a chemical agent and method of such introduction

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE APPLICANT TO READ ADPROTECH LIMITED

FGA Letters patent sealed or granted (standard patent)